Pharma CRM Goes on the iPad and iPhone

Media-SoftMedia-Soft, CRM solutions provider for pharmaceutical companies, announced the launch of the native and offline iPhone adn iPad Pharma CRM application with advanced and unique features that increase the Sales Force effectiveness in pharma organizations.

"Fast, simple, functional and revolutionary are the main goals of our Sales Force Effectiveness solutions for the iPhone, iPad and iPod Touch platforms. Now every sales rep can handle customers offline on the iPad, iPhone or iPod Touch via Sales Vision iTouch application, it's so simple," commented Mr. Damir Safaric, Media-Soft CEO. "It is called Sales Vision iTouch, the best way for Pharma CRM that can revolutionize the pharma processes and increase the sales rep efficiency."

The Pharma CRM application has a simple and comfortable natural user interface that has retained all the functionality of the original Sales Vision® and in special the access to the database online and offline, all actions can be moved to the PC version through the user friendly and intuitive touch screen navigation. Also Sales Vision iTouch enables a parallel use of platforms, so a sales rep can use the iPhone or iPad on the sales field and when he arrives home he can add new information's via his PC version, Sales Vision 9 WIN.

"There are many reasons why Sales Vision CRM goes to the iPhone. Sales Vision® and iPhone are similar because they both have remained true to its roots. Both operate in niches and seek to satisfy their customers. Sales Vision® looks better than ever on iPhone. Also if you look ten years ago, the main add value and motivation factor for a sales rep was to gain a laptop. Times have changed and today the add value is to have the best Smartphone," concluded Mr. Safaric.

For further information, please visit:
http://www.media-soft.info

About Media-Soft
The story of Media Soft begins in 1996 when a visionary man started up a company that must be the best in the pharmaceutical field. Today that mission is done, Media-Soft operates in more then 30 countries worldwide, on 3 continents and has over 6.000 licensed users of its software Sales Vision®. Media Soft is established on many locations. The HQ is in Cakovec and London. We also have partners and support teams worldwide in following countries: Mexico City, Bratislava, Warszawa and Moscow. Some of the customer are Pfizer, Krka, Sandoz, Solvay, Abbott, Alkaloid, GSK, Nycomed, Roche, Bayer Schering Pharma and many others.

Most Popular Now

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

COVID-19 vaccines, prior infection reduce transmis…

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...